{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG|Designated/Withdrawn" in comments (approximate match)
Status:
Investigational
Source:
INN:libivirumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00041652: Phase 1/Phase 2 Interventional Completed Colorectal Cancer
(2000)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04050462: Phase 2 Interventional Active, not recruiting Hepatocellular Carcinoma
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01574716: Phase 2 Interventional Completed Metastatic Soft Tissue Sarcoma
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02841267: Phase 1/Phase 2 Interventional Completed LGMD2I
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03290781: Phase 3 Interventional Completed Ulcerative Colitis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02573467: Phase 3 Interventional Completed Sporadic Inclusion Body Myositis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03739606: Phase 2 Interventional Withdrawn Acute Biphenotypic Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01995188: Phase 1 Interventional Completed Non-Squamous Non-Small Cell Lung Cancer
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01647828: Phase 1/Phase 2 Interventional Completed Stage IV Pancreatic Cancer
(2012)
Source URL:
Class:
PROTEIN